FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
What's Your Reaction?
Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Total Vote: 0
Send Message on kartavyasolution@gmail.com
